Apollo Hospitals Enterprise Limited

Apollo Hospitals Enterprise Limited (APOLLOHOSP) is a large-cap Healthcare company valued at ₹1.14 lakh crore operating in Hospital on the NSE and BSE.

Recent price move

Apollo Hospitals Enterprise Limited last traded at ₹7,890, modestly up 0.01% on the day.

Recent developments

On 2026-09-30, Apollo Hospitals' stock fell along with other hospital stocks, declining 6% amid market concerns. On 2026-07-08, the company announced the outcome of a board meeting held on 2026-05-20, which included decisions on dividend distributions.

Financial performance

Apollo Hospitals' business is improving, with annual revenue rising 15.8% and net profit growing 33.1% year-over-year. The latest quarter saw revenue and net profit both rising sharply, with revenue up 20.6% and net profit up 38.4% compared to the same quarter a year earlier. Margins have improved, with the net profit margin rising 1.0 percentage points to 7.9%, and returns remain strong, with return on equity at 20.5%.

Valuation multiples

The stock trades at 58.4 times earnings, a premium to the Healthcare median of 32.0, 13.46 times book value. It yields 0.2%.

Things to watch

The stock is 13.0% below its 52-week high, indicating a significant pullback from recent peak levels. Promoter shares pledged amount to 2.91% of their holding, which could signal short-term liquidity concerns. The company's debt to equity ratio is 0.90, which is relatively high and could increase financial risk if interest rates rise.

Where it stands

Apollo Hospitals has delivered strong revenue and profit growth over the past year and quarter, with margins and returns remaining robust. The stock's recent decline and promoter pledging are notable factors, but the company's long-term growth trajectory remains positive. The stock is currently 13.0% below its 52-week high.

Summarised by DocStoX's model on 2026-10-17 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.